Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls
GHDx Entry last modified on: Mar 14, 2022
HPV vaccines
Dataset Records for HPV vaccines
Displaying 301 - 350 of 364
Progress toward implementation of human papillomavirus vaccination-the Americas, 2006-2010
GHDx Entry last modified on: Apr 14, 2022
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness of human papilloma virus vaccination in Iceland
GHDx Entry last modified on: Jan 31, 2023
Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012
GHDx Entry last modified on: Mar 14, 2022
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries
GHDx Entry last modified on: Jan 31, 2023
Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine
GHDx Entry last modified on: Mar 14, 2022
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta
GHDx Entry last modified on: Mar 14, 2022
Marshall Islands Ministry of Health Annual Report 2011
Report:
Financial - Inpatient - Operational - Outpatient
Economic evaluation of human papillomavirus vaccination in the United Kingdom
GHDx Entry last modified on: Jan 31, 2023
Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases
GHDx Entry last modified on: Mar 14, 2022
Socioeconomic predictors of human papillomavirus vaccination in Danish men - A nationwide study
GHDx Entry last modified on: Mar 14, 2022
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
GHDx Entry last modified on: May 30, 2020
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis
GHDx Entry last modified on: May 30, 2020
Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
GHDx Entry last modified on: Jan 31, 2023
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
GHDx Entry last modified on: Jan 31, 2023
A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
GHDx Entry last modified on: May 30, 2020
Rwanda Health Statistics Booklet 2012
Report:
Discharge - Epi surveillance - Financial - Inpatient - Outpatient - Subnationally representative
Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
GHDx Entry last modified on: Jan 31, 2023
Rwanda Annual Health Statistics Booklet 2013
Report:
Discharge - Epi surveillance - Financial - Inpatient - Outpatient - Subnationally representative
The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan
GHDx Entry last modified on: Jan 31, 2023
Model for assessing human papillomavirus vaccination strategies
GHDx Entry last modified on: Jan 31, 2023
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
GHDx Entry last modified on: Jan 31, 2023
Mathematical models of cervical cancer prevention in Latin America and the Caribbean
GHDx Entry last modified on: Jan 31, 2023
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors-United States, 2005-2013
GHDx Entry last modified on: Apr 14, 2022
United States National Health and Nutrition Examination Survey 2005-2006
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Mathematical models of cervical cancer prevention in the Asia Pacific region
GHDx Entry last modified on: Jan 31, 2023
The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK
GHDx Entry last modified on: Jan 31, 2023
Health and economic implications of HPV vaccination in the United States
GHDx Entry last modified on: May 30, 2020
Assessment of the cost-effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
GHDx Entry last modified on: Jan 31, 2023
Cost-utility analysis of vaccination against HPV in Israel
GHDx Entry last modified on: May 30, 2020
Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness of human papillomavirus vaccination in the United States
GHDx Entry last modified on: Jan 31, 2023
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
GHDx Entry last modified on: Jan 31, 2023
Age-based programs for vaccination against HPV
GHDx Entry last modified on: May 30, 2020
Australia Immunisation Coverage Annual Report 2013
Report:
Subnationally representative
Spain Vaccination Coverage Statistical Data
GHDx Entry last modified on: Nov 6, 2018
Australia Immunisation Coverage Annual Report 2014
Report:
Subnationally representative
A multi-type HPV transmission model
GHDx Entry last modified on: Jan 31, 2023
Malaysia Ministry of Health Annual Report 2011
Annual Report Ministry of Health Malaysia 2011
Report:
Discharge - Financial - Inpatient - Operational - Outpatient
Australia Immunisation Coverage Annual Report 2012
Report:
Subnationally representative
Latvia Health Statistical Yearbook 2012
Latvijas Veselības Aprūpes Statistikas Gadagrāmata 2012
Report:
Epi surveillance - Financial - Outpatient - Subnationally representative - Urban-rural representative
Cost-effectiveness of a potential vaccine for human papillomavirus
GHDx Entry last modified on: May 30, 2020
Subscribe